34700 Federal Register / Vol. 66, No. 126 / Friday, June 29, 2001 / Notices

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Heart, Lung,

and Blood Institute Special Emphasis Panel,

Minority Undergraduate Biomedical

Education Program.

Date: July 13, 2001.

Time: 8:00 am to 4:00 pm.

Agenda: To review and evaluate grant

applications.

Place: 5520 Wisconsin Avenue, Chevy

Chase, MD 20815.

Contact Person: Roy L White, Review

Branch, NIH, NHLBI, Rockledge Building II,

6701 Rockledge Drive, Room 7196, Bethesda,

MD 20892, 301–435–0291.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.233, National Center for

Sleep Disorders Research; 93.837, Heart and

Vascular Diseases Research; 93.838, Lung

Diseases Research; 93.839, Blood Diseases

and Resources Research, National Institutes

of Health, HHS)

Dated: June 22, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–16338 Filed 6–28–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Heart, Lung, and Blood

Institute; Notice of Meeting

Pursuant to section 10(a) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be open to the

public, with attendance limited to space

available. Individuals who plan to

attend and need special assistance, such

as sign language interpretation or other

reasonable accommodations, should

notify the Contact Person listed below

in advance of the meeting.

Name of Committee: National Heart, Lung,

and Blood Institute Special Emphasis Panel,

Stem Cell Plasticity in Hematopoietic and

Non-Hematopoietic Tissue.

Date: July 10–11, 2001.

Time: 8 a.m. to 5 p.m.

Agenda: To provide concept review of

proposed grant applications.

Place: Holiday Inn, 5520 Wisconsin

Avenue, Chevy Chase, MD 20815.

Contact Person: Robert B. Moore, Scientific

Review Administrator, Review Branch, Room

7192, Division of Extramural Affairs,

National Heart, Lung, and Blood Institute,

National Institutes of Health, Bethesda, MD

20892, 301–435–3541,

mooreb@nhlbi.nih.gov.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.233, National Center for

Sleep Disorders Research; 93.837, Heart and

Vascular Diseases Research; 93.838, Lung

Diseases Research; 93.839, Blood Diseases

and Resources Research, National Institutes

of Health, HHS)

Dated: June 22, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–16339 Filed 6–28–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Heart, Lung and Blood

Institute; Amended Notice of Meeting

Notice is hereby given of a change in

the meeting of the Sleep Disorders

Research Advisory Board, June 26, 2001,

8 am to June 26, 2001, 5 pm, National

Institutes of Health, Natcher Building

45, Conference Room D, 9000 Rockville

Pike, Bethesda, MD, 20892 which was

published in the Federal Register on

April 26, 2001, FR 66:21000.

The meeting location will change to

the Neuroscience Center, Conference

Room D, National Institutes of Health,

6001 Executive Boulevard, Bethesda,

Maryland 20892. The meeting is open to

the public.

Dated: June 22, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–16362 Filed 6–28–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of General Medical

Sciences; Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given the following meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections 552(c)(4)

and 552b(c)(6), Title 5 U.S.C., as

amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

General Medical Sciences Special Emphasis

Panel, MBRS Special Emphasis Panel.

Date: July 25, 2001.

Time: 1 pm to 3 pm.

Agenda: To review and evaluate grant

applications.

Place: National Institutes of Health,

NIGMS, Office of Scientific Review, Natcher

Building, Room 1AS–13, Bethesda, MD

20892, (Telephone Conference Call).

Contact Person: Helen R. Sunshine, Chief,

Office of Scientific Review, NIGMS, Natcher

Building, Room 1AS–13, Bethesda, MD

20892, (301) 594–2881.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.375, Minority Biiomedical

Research Support; 93.821, Cell Biology and

Biophysics Research; 93.859, Pharmacology,

Physiology, and Biological Chemistry

Research; 93.862, Genetics and

Developmental Biology Research; 93.88,

Minority Access to Research Careers; 93.96,

Special Minority Initiatives, National

Institutes of Health, HHS)

Dated: June 21, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–16332 Filed 6–28–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Child Health and

Human Development; Notice of Closed

Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Child Health and Human Development

Special Emphasis Panel.

Date: July 26, 2001.